Analytical Data
-
Gene name
TEC
- Application
-
Alternative Names
PSCTK4
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P24604
-
Expression Region
Leu369~Val622
-
Molecular Weight
33kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TEC (T-Cell Exuberant Cytokine) recombinants are a class of proteins that play a crucial role in understanding immune responses and therapeutic applications in immunology. The research background of TEC recombinant proteins stems from the need to elucidate the complex mechanisms underlying T-cell activation, differentiation, and cytokine production. T-cells are essential components of the adaptive immune system, and their dysregulation can lead to various diseases, including autoimmune disorders, infections, and cancer. By engineering recombinant forms of TEC proteins, researchers aim to dissect their functional roles and signaling pathways. These studies are empowered by advancements in molecular biology techniques, enabling the precise manipulation of protein structures and the development of novel therapeutic agents. Moreover, the therapeutic potential of TEC recombinants in enhancing vaccine efficacy or modulating immune responses highlights their significance in clinical settings. Understanding the structure-function relationships of TEC proteins may also open avenues for innovative strategies in personalized medicine, where tailored treatments can optimize immune responses for individual patients. Overall, the exploration of TEC recombinant proteins is pivotal for advancing our comprehension of immune regulation and developing cutting-edge therapies to combat immune-related diseases.
